pharmaceuticals
pharmaceuticals Articles
The April 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
Eli Lilly released its most recent quarterly earnings report before the markets opened on Tuesday.
Published:
Last Updated:
Creating a treatment for a rare disease or rare disorder can come with massive upside if the treatment is successful. That said, the risk is that a company can implode if its rare disease treatment...
Published:
Last Updated:
24/7 Wall St. has put together a preview of AbbVie, Eli Lilly and some of the other top pharma and biotech companies reporting their latest quarterly results in the coming week.
Published:
Last Updated:
Incyte and Eli Lilly will be under the microscope next week as the FDA will decide the fate of their rheumatoid arthritis treatment.
Published:
Last Updated:
Ionis Pharmaceuticals shares made a handy gain on Friday after the firm announced an expanded strategic collaboration with Biogen.
Published:
Last Updated:
GW Pharmaceuticals won an FDA approval for its cannabis-derived drug, but shares were relatively muted on Thursday.
Published:
Last Updated:
Rigel Pharmaceuticals shares retreated early Wednesday despite an approval from the FDA for its treatment of thrombocytopenia.
Published:
Last Updated:
GW Pharmaceuticals shares saw a solid gain on Tuesday after the FDA released some briefing documents pertaining to an upcoming approval meeting. Needless to say, investors are taking this as a...
Published:
Last Updated:
Rheumatoid arthritis is an autoimmune disease that attacks tissues within the joints, and it is a major target of U.S. and foreign biotechnology and pharmaceutical companies.
Published:
Last Updated:
Bellicum Pharmaceuticals shares pulled back on Tuesday after the firm announced that it would be conducting a secondary offering to raise some cash.
Published:
Last Updated:
Johnson & Johnson (NYSE: JNJ) reported its first quarter financial results before the markets opened on Tuesday. The company said that it had $2.06 in earnings per share (EPS) on $20.01 billion...
Published:
Last Updated:
Lung cancer may have just met a new standard of care. On top of that, it would be considered a new standard as a first line of care in lung cancer and longer overall survival rates.
Published:
Last Updated:
Over the past week, a few biotech companies made absolutely massive runs, while others fell off a cliff. Although health care has barely kept pace with the broader markets over the past 52 weeks, the...
Published:
Last Updated:
Bellicum Pharmaceuticals saw its shares rise early on Thursday after the firm announced a critical decision from the FDA.
Published:
Last Updated: